Evidence map›Paper›PMID 25765876›Full record

Trial reportThe oncologist2015

Geriatric assessment-identified deficits in older cancer patients with normal performance status.

Trevor A Jolly, Allison M Deal, Kirsten A Nyrop, Grant R Williams, Mackenzi Pergolotti, William A Wood, Shani M Alston, Brittaney-Belle E Gordon, Samara A Dixon, Susan G Moore and 3 more

Open access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in The oncologist, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 115 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
115citing papers in PubMed, 2 pooled it
10.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

115 citing papers in PubMed, 2 syntheses or guidelines pooled it, 226 citations in OpenAlex.

  1. Guideline
  2. Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy: ASCO Guideline Update.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023
    Guideline
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Unmet cancer rehabilitation needs and access to survivorship services across the cancer continuum.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Observational
  8. Article
  9. Review
  10. Neutrophile-to-lymphocyte ratio predicts survival in patients aged 80 years and older undergoing radiotherapy: a single-center experience.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2026
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Cumulative frailty impact on unplanned hospitalization in older patients with cancer and excellent Eastern Cooperative Oncology Group performance.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Observational
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review

55 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Trevor A JollyHematology and Oncology Division and Center for Aging and Health/Division of Geriatric Medicine, School of Medicine, Lineberger Comprehensive Cancer Center, and Gillings School of Global Public Health, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, USA; Rex Hematology Oncology Associates, Raleigh, North Carolina, USA; New Bern Cancer Care, New Bern, North Carolina, USA; Cancer Care of Western North Carolina (Affiliate of Mission Health), Asheville, North Carolina, USA trevor_jolly@med.unc.edu.
Allison M DealHematology and Oncology Division and Center for Aging and Health/Division of Geriatric Medicine, School of Medicine, Lineberger Comprehensive Cancer Center, and Gillings School of Global Public Health, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, USA; Rex Hematology Oncology Associates, Raleigh, North Carolina, USA; New Bern Cancer Care, New Bern, North Carolina, USA; Cancer Care of Western North Carolina (Affiliate of Mission Health), Asheville, North Carolina, USA.
Kirsten A NyropHematology and Oncology Division and Center for Aging and Health/Division of Geriatric Medicine, School of Medicine, Lineberger Comprehensive Cancer Center, and Gillings School of Global Public Health, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, USA; Rex Hematology Oncology Associates, Raleigh, North Carolina, USA; New Bern Cancer Care, New Bern, North Carolina, USA; Cancer Care of Western North Carolina (Affiliate of Mission Health), Asheville, North Carolina, USA.
Grant R WilliamsHematology and Oncology Division and Center for Aging and Health/Division of Geriatric Medicine, School of Medicine, Lineberger Comprehensive Cancer Center, and Gillings School of Global Public Health, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, USA; Rex Hematology Oncology Associates, Raleigh, North Carolina, USA; New Bern Cancer Care, New Bern, North Carolina, USA; Cancer Care of Western North Carolina (Affiliate of Mission Health), Asheville, North Carolina, USA.
Mackenzi PergolottiHematology and Oncology Division and Center for Aging and Health/Division of Geriatric Medicine, School of Medicine, Lineberger Comprehensive Cancer Center, and Gillings School of Global Public Health, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, USA; Rex Hematology Oncology Associates, Raleigh, North Carolina, USA; New Bern Cancer Care, New Bern, North Carolina, USA; Cancer Care of Western North Carolina (Affiliate of Mission Health), Asheville, North Carolina, USA.
William A WoodHematology and Oncology Division and Center for Aging and Health/Division of Geriatric Medicine, School of Medicine, Lineberger Comprehensive Cancer Center, and Gillings School of Global Public Health, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, USA; Rex Hematology Oncology Associates, Raleigh, North Carolina, USA; New Bern Cancer Care, New Bern, North Carolina, USA; Cancer Care of Western North Carolina (Affiliate of Mission Health), Asheville, North Carolina, USA.
Shani M AlstonHematology and Oncology Division and Center for Aging and Health/Division of Geriatric Medicine, School of Medicine, Lineberger Comprehensive Cancer Center, and Gillings School of Global Public Health, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, USA; Rex Hematology Oncology Associates, Raleigh, North Carolina, USA; New Bern Cancer Care, New Bern, North Carolina, USA; Cancer Care of Western North Carolina (Affiliate of Mission Health), Asheville, North Carolina, USA.
Brittaney-Belle E GordonHematology and Oncology Division and Center for Aging and Health/Division of Geriatric Medicine, School of Medicine, Lineberger Comprehensive Cancer Center, and Gillings School of Global Public Health, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, USA; Rex Hematology Oncology Associates, Raleigh, North Carolina, USA; New Bern Cancer Care, New Bern, North Carolina, USA; Cancer Care of Western North Carolina (Affiliate of Mission Health), Asheville, North Carolina, USA.
Samara A DixonHematology and Oncology Division and Center for Aging and Health/Division of Geriatric Medicine, School of Medicine, Lineberger Comprehensive Cancer Center, and Gillings School of Global Public Health, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, USA; Rex Hematology Oncology Associates, Raleigh, North Carolina, USA; New Bern Cancer Care, New Bern, North Carolina, USA; Cancer Care of Western North Carolina (Affiliate of Mission Health), Asheville, North Carolina, USA.
Susan G MooreHematology and Oncology Division and Center for Aging and Health/Division of Geriatric Medicine, School of Medicine, Lineberger Comprehensive Cancer Center, and Gillings School of Global Public Health, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, USA; Rex Hematology Oncology Associates, Raleigh, North Carolina, USA; New Bern Cancer Care, New Bern, North Carolina, USA; Cancer Care of Western North Carolina (Affiliate of Mission Health), Asheville, North Carolina, USA.
W Chris TaylorHematology and Oncology Division and Center for Aging and Health/Division of Geriatric Medicine, School of Medicine, Lineberger Comprehensive Cancer Center, and Gillings School of Global Public Health, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, USA; Rex Hematology Oncology Associates, Raleigh, North Carolina, USA; New Bern Cancer Care, New Bern, North Carolina, USA; Cancer Care of Western North Carolina (Affiliate of Mission Health), Asheville, North Carolina, USA.
Michael MessinoHematology and Oncology Division and Center for Aging and Health/Division of Geriatric Medicine, School of Medicine, Lineberger Comprehensive Cancer Center, and Gillings School of Global Public Health, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, USA; Rex Hematology Oncology Associates, Raleigh, North Carolina, USA; New Bern Cancer Care, New Bern, North Carolina, USA; Cancer Care of Western North Carolina (Affiliate of Mission Health), Asheville, North Carolina, USA.
Hyman B MussHematology and Oncology Division and Center for Aging and Health/Division of Geriatric Medicine, School of Medicine, Lineberger Comprehensive Cancer Center, and Gillings School of Global Public Health, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, USA; Rex Hematology Oncology Associates, Raleigh, North Carolina, USA; New Bern Cancer Care, New Bern, North Carolina, USA; Cancer Care of Western North Carolina (Affiliate of Mission Health), Asheville, North Carolina, USA.
UNC Lineberger Comprehensive Cancer CenterUniversity of North Carolina at Chapel Hill · USCancerCare · USCancer Care of Western North Carolina · USHematology Oncology Associates · US

Funding

Tissue Procurement & PathologyP50CA058223 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LISA A CAREY, Gaorav P. Gupta · 1992 to 2026
$59.3M
UNC Oncology K12K12CA120780 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WILLIAM Y. KIM · 2007 to 2026
$9.6M
Cancer Training GrantR25CA116339 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BASCH, ETHAN M., REEVE, BRYCE B · 2008 to 2017
$4.0M
NCI NIH HHS K12 CA120780NCI NIH HHS P50 CA058223NCI NIH HHS R25 CA116339
6 · The paper itself

Abstract

backgroundWe investigated whether a brief geriatric assessment (GA) would identify important patient deficits that could affect treatment tolerance and care outcomes within a sample of older cancer patients rated as functionally normal (80%-100%) on the Karnofsky performance status (KPS) scale.

methodsCancer patients aged ≥65 years were assessed using a brief GA that included both professionally and patient-scored KPS and measures of comorbidity, polypharmacy, cognition, function, nutrition, and psychosocial status. Data were analyzed using descriptive statistics and multivariable logistic regression.

resultsThe sample included 984 patients: mean age was 73 years (range: 65-99 years), 74% were female, and 89% were white. GA was conducted before (23%), during (41%), or after (36%) treatment. Overall, 54% had a breast cancer diagnosis (n = 528), and 46% (n = 456) had cancers at other sites. Moreover, 81% of participants (n = 796) had both professionally and self-rated KPS ≥80, defined as functionally normal, and those patients are the focus of analysis. In this subsample, 550 (69%) had at least 1 GA-identified deficit, 222 (28%) had 1 deficit, 140 (18%) had 2 deficits, and 188 (24%) had ≥3 deficits. Specifically, 43% reported taking ≥9 medications daily, 28% had decreased social activity, 25% had ≥4 comorbidities, 23% had ≥1 impairment in instrumental activities of daily living, 18% had a Timed Up and Go time ≥14 seconds, 18% had ≥5% unintentional weight loss, and 12% had a Mental Health Index score ≤76.

conclusionWithin this sample of older cancer patients who were rated as functionally normal by KPS, GA identified important deficits that could affect treatment tolerance and outcomes.

Indexed as

Karnofsky Performance StatusNeoplasmsAgedAged, 80 and overFemaleGeriatric AssessmentHumansMaleMental HealthMultivariate AnalysisSocial BehaviorSocial SupportCancerGeriatric assessmentOlderPerformance status

Identifiers

PMID25765876
PMCPMC4391761
OpenAlexW2096376437

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.